There are no official announcements or corporate filings from Assertio Holdings indicating plans for a forward or reverse stock split. Management focuses its strategic communications primarily on operational execution, integrating acquired pharmaceutical assets, managing capital structures, and driving long-term revenue growth rather than altering share counts through market splits.